FSMAX
Price
$117.72
Change
-$1.39 (-1.17%)
Updated
Aug 20 closing price
Net Assets
40.08B
JCNIX
Price
$31.62
Change
-$0.18 (-0.57%)
Updated
Aug 20 closing price
Net Assets
5.04B
Interact to see
Advertisement

FSMAX vs JCNIX

FSMAX vs JCNIX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. JCNIX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and JCNIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. JCNIX (5.04B). FSMAX pays higher dividends than JCNIX: FSMAX (0.50) vs JCNIX (0.00). FSMAX was incepted earlier than JCNIX: FSMAX (15 years) vs JCNIX (17 years). JCNIX (1.23) is less costly to investors than FSMAX (0.04). JCNIX is a more actively managed with annual turnover of: 52.00 vs. FSMAX (23.00). FSMAX has a lower initial minimum investment than JCNIX: FSMAX (0) vs JCNIX (2500). FSMAX annual gain was more profitable for investors over the last year : 23.68 vs. JCNIX (9.26). FSMAX return over 5 years is better than : 40.14 vs. JCNIX (0.91).
FSMAXJCNIXFSMAX / JCNIX
Total Expense Ratio0.041.113%
Annual Report Gross Expense Ratio0.041.233%
Fund Existence15 years17 years-
Gain YTD16.93719.27688%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets40.1B5.04B796%
Annual Yield % from dividends0.500.00-
Returns for 1 year23.689.26256%
Returns for 3 years72.7424.25300%
Returns for 5 years40.140.914,431%
Returns for 10 years134.4971.31189%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGAIX51.350.59
+1.16%
American Funds Intl Gr and Inc F-3
WAMVX4.940.05
+1.02%
Wasatch Micro Cap Value
RUSTX18.850.11
+0.59%
Russell Inv US Strategic Equity M
RTSGX5.740.02
+0.35%
Transamerica Small Cap Growth R6
HFDRX21.870.06
+0.28%
Hartford Schroders US MidCap Opps R3